Adrenomedullin in Breast Cancer
Author Information
Author(s): Oehler M K, Fischer D C, Orlowska-Volk M, Herrle F, Kieback D G, Rees M C P, Bicknell R
Primary Institution: Cancer Research UK, University of Oxford
Hypothesis
Does adrenomedullin expression in breast cancer tissues correlate with clinical outcomes?
Conclusion
Adrenomedullin is widely expressed in breast malignancies and its levels in plasma may reflect tumor size and lymph node involvement.
Supporting Evidence
- 82% of breast cancer samples showed moderate to strong adrenomedullin staining.
- Patients with lymph node metastasis had higher adrenomedullin expression.
- Plasma adrenomedullin levels were significantly higher in patients with larger tumors.
Takeaway
This study looked at a substance called adrenomedullin in breast cancer and found that higher levels might mean the cancer is more serious.
Methodology
The study examined adrenomedullin expression in breast cancer tissues and plasma samples from patients and healthy controls using immunohistochemistry and radioimmunoassay.
Potential Biases
Potential bias in patient selection and the retrospective nature of the study.
Limitations
The study had a limited sample size and did not find correlations with all clinicopathological features.
Participant Demographics
33 breast cancer patients and 18 healthy female controls.
Statistical Information
P-Value
0.030
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website